BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Loncipoetin alfa (NuPIAO) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Loncipoetin alfa (NuPIAO)\, from Clinical
 Trials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06854276-906@assetmemo.bio
DTSTAMP:20261121T010012Z
DTSTART;VALUE=DATE:20271201
DTEND;VALUE=DATE:20271202
SUMMARY:Loncipoetin alfa (NuPIAO): Phase 2 readout est. (NCT06854276)
DESCRIPTION:Loncipoetin alfa (NuPIAO)\, phase 2.\nStudy: Study of SSS06 for
  Chemotherapy-Induced Anemia in Non-Myeloid Malignancies\nEstimated primar
 y completion: 1 December 2027. This is a ClinicalTrials.gov estimate\, not
  a confirmed readout date\, and it can move.\nDrug page: https://assetmemo
 .bio/drug/loncipoetin-alfa-nupiao#upcoming-events\nRegistry record: https:
 //clinicaltrials.gov/study/NCT06854276
URL:https://assetmemo.bio/drug/loncipoetin-alfa-nupiao#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
